• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diabetes care needs evidence based interventions to reduce risk of vascular disease.

作者信息

Byrne C D, Wild S H

出版信息

BMJ. 2000 Jun 10;320(7249):1554-5.

PMID:10845947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1127353/
Abstract
摘要

相似文献

1
Diabetes care needs evidence based interventions to reduce risk of vascular disease.糖尿病护理需要基于证据的干预措施来降低血管疾病的风险。
BMJ. 2000 Jun 10;320(7249):1554-5.
2
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.2 型糖尿病患者无症状心肌梗死的发生率和预测因素及非诺贝特的作用：来自非诺贝特干预和糖尿病事件降低（FIELD）研究的分析。
Eur Heart J. 2010 Jan;31(1):92-9. doi: 10.1093/eurheartj/ehp377. Epub 2009 Sep 29.
3
Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.糖尿病患者降低低密度脂蛋白胆固醇所需的大规模随机证据：医学研究委员会/英国心脏基金会心脏保护研究及其他主要试验
Heart. 2000 Oct;84(4):357-60. doi: 10.1136/heart.84.4.357.
4
[Myocardial infarction in patients with diabetes mellitus type 2].[2型糖尿病患者的心肌梗死]
Kardiol Pol. 1988;31(9):563-8.
5
Should you put all diabetic patients on statins?是否应该让所有糖尿病患者服用他汀类药物？
J Fam Pract. 2007 Apr;56(4):294-300.
6
Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?治疗与临床试验：2型糖尿病中的贝特类药物治疗——我们目前的进展如何？
Curr Opin Lipidol. 2010 Dec;21(6):554-5. doi: 10.1097/MOL.0b013e3283404ff1.
7
[Critical evaluation of a "therapeutic study"].["一项“治疗性研究”的批判性评价"]
Praxis (Bern 1994). 1997 Oct 8;86(41):1603-7.
8
Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.性别对心肌梗死合并 2 型糖尿病患者预后的影响。
J Intern Med. 2010 Jul;268(1):75-82. doi: 10.1111/j.1365-2796.2010.02215.x. Epub 2010 Jan 20.
9
Electrocardiographic abnormalities in diabetes mellitus: association between T-wave changes and nephropathy.糖尿病中的心电图异常：T波改变与肾病之间的关联。
Mt Sinai J Med. 1986 Apr;53(4):254-9.
10
[Dangerous duo: hypertension and pre-diabetes--the underestimated risk].危险组合：高血压与糖尿病前期——被低估的风险
MMW Fortschr Med. 2003 Jan 23;145(3-4):54-5.

引用本文的文献

1
Effects of a Walking Program on Self-management and Risk Factors of Metabolic Syndrome in Older Korean Adults.步行计划对韩国老年成年人代谢综合征自我管理及危险因素的影响。
J Phys Ther Sci. 2014 Jan;26(1):105-9. doi: 10.1589/jpts.26.105. Epub 2014 Feb 6.
2
Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies.2型糖尿病患者与心肌梗死患者心血管风险的比较：横断面研究与队列研究
BMJ. 2002 Apr 20;324(7343):939-42. doi: 10.1136/bmj.324.7343.939.
3
Lifestyle modification may be beneficial in diabetes care.生活方式的改变可能对糖尿病护理有益。
BMJ. 2000 Sep 23;321(7263):768.

本文引用的文献

1
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.雷米普利对糖尿病患者心血管和微血管结局的影响：HOPE研究及MICRO-HOPE子研究结果。心脏结局预防评估研究组。
Lancet. 2000 Jan 22;355(9200):253-9.
2
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.血管紧张素转换酶抑制剂雷米普利对高危患者心血管事件的影响。
N Engl J Med. 2000 Jan 20;342(3):145-53. doi: 10.1056/NEJM200001203420301.
3
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.辛伐他汀治疗冠心病合并糖尿病或空腹血糖受损患者可减少冠脉事件：斯堪的纳维亚辛伐他汀生存研究中的亚组分析
Arch Intern Med. 1999;159(22):2661-7. doi: 10.1001/archinte.159.22.2661.
4
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.吉非贝齐用于高密度脂蛋白胆固醇水平低的男性冠心病二级预防。退伍军人事务部高密度脂蛋白胆固醇干预试验研究组。
N Engl J Med. 1999 Aug 5;341(6):410-8. doi: 10.1056/NEJM199908053410604.
5
Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.英国关于临床实践中冠心病预防的联合建议。英国心脏病学会、英国高脂血症协会、英国高血压学会，获英国糖尿病协会认可。
Heart. 1998 Dec;80 Suppl 2(Suppl 2):S1-29.
6
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.普伐他汀对冠心病及初始胆固醇水平范围广泛的患者心血管事件和死亡的预防作用。
N Engl J Med. 1998 Nov 5;339(19):1349-57. doi: 10.1056/NEJM199811053391902.
7
Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.临床实践中冠心病的预防。欧洲及其他学会冠心病预防联合特别工作组第二次报告的建议
Eur Heart J. 1998 Oct;19(10):1434-503. doi: 10.1053/euhj.1998.1243.
8
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较（英国前瞻性糖尿病研究[UKPDS 33]）。英国前瞻性糖尿病研究（UKPDS）小组
Lancet. 1998 Sep 12;352(9131):837-53.
9
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.2型糖尿病患者严格血压控制与大血管及微血管并发症风险：英国前瞻性糖尿病研究（UKPDS 38）。英国前瞻性糖尿病研究小组
BMJ. 1998 Sep 12;317(7160):703-13.
10
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.2型糖尿病患者以及有和没有既往心肌梗死的非糖尿病患者的冠心病死亡率。
N Engl J Med. 1998 Jul 23;339(4):229-34. doi: 10.1056/NEJM199807233390404.